Worldline (DB:WO6) Stock Valuation, Peer Comparison & Price Targets

Q: What is the Fair Price of WO6 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

WO6 (€6.41) is trading below our estimate of [[fair value]] (€17.77)

Share Price vs Fair Value

What is the Fair Price of WO6 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WO6 (€6.41) is trading below our estimate of fair value (€17.77)

Significantly Below Fair Value: WO6 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for WO6?

Key metric: As WO6 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for WO6. This is calculated by dividing WO6's market cap by their current revenue.
What is WO6's PS Ratio?
PS Ratio	0.4x
Sales	€4.66b
Market Cap	€1.82b

WO6 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1x
Enterprise Value/EBITDA	6.3x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does WO6's PS Ratio compare to its peers?

The above table shows the PS ratio for WO6 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.5x
HYQ Hypoport	3.3x	11.5%	€1.4b
GLJ Grenke	1.4x	14.1%	€731.6m
FTK flatexDEGIRO	3.3x	6.1%	€1.5b
PBB Deutsche Pfandbriefbank	1.9x	12.0%	€691.9m
WO6 Worldline	0.4x	3.2%	€1.8b

Price-To-Sales vs Peers: WO6 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (2.5x).

Price to Sales Ratio vs Industry

How does WO6's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 Companies	Price / Sales	Estimated Growth	Market Cap
EBEN aifinyo	0.3x	n/a	US$15.51m
EBEN aifinyo	0.2x	n/a	US$13.94m
CSQ creditshelf	0.005x	n/a	US$29.30k

No more companies available in this PS range

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: WO6 is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Diversified Financial industry average (1.9x).

Price to Sales Ratio vs Fair Ratio

What is WO6's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WO6 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.4x
Fair PS Ratio	2.8x

Price-To-Sales vs Fair Ratio: WO6 is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WO6 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€6.41	€9.66 +50.6%	43.0%	€22.00	€5.00	n/a	20
Nov ’25	€6.34	€9.78 +54.3%	42.2%	€22.00	€5.00	n/a	20
Oct ’25	€5.99	€10.87 +81.5%	36.2%	€22.00	€6.70	n/a	20
Sep ’25	€8.27	€13.32 +61.2%	38.8%	€28.90	€7.00	n/a	20
Aug ’25	€8.91	€14.29 +60.4%	34.1%	€28.90	€9.00	n/a	20
Jul ’25	€10.37	€14.46 +39.4%	32.8%	€28.90	€9.00	n/a	20
Jun ’25	€12.12	€14.66 +20.9%	33.1%	€28.90	€9.00	n/a	20
May ’25	€9.80	€14.62 +49.2%	33.3%	€28.90	€9.00	n/a	20
Apr ’25	€11.41	€15.04 +31.8%	34.0%	€28.90	€9.00	n/a	21
Mar ’25	€10.85	€16.04 +47.8%	33.6%	€28.90	€9.00	n/a	20
Feb ’25	€12.24	€18.08 +47.7%	35.9%	€36.00	€10.90	n/a	20
Jan ’25	€15.77	€22.92 +45.3%	77.2%	€91.00	€10.90	n/a	20
Dec ’24	€15.67	€22.68 +44.7%	78.7%	€91.00	€8.90	n/a	20
Nov ’24	€12.20	€26.16 +114.4%	72.5%	€91.00	€8.90	€6.34	19
Oct ’24	€26.77	€54.24 +102.6%	22.2%	€91.00	€30.20	€5.99	19
Sep ’24	€29.40	€54.54 +85.5%	21.7%	€91.00	€35.90	€8.27	20
Aug ’24	€34.82	€54.71 +57.1%	21.3%	€91.00	€35.90	€8.91	20
Jul ’24	€33.43	€55.16 +65.0%	20.6%	€91.00	€35.90	€10.37	20
Jun ’24	€36.32	€55.62 +53.1%	19.4%	€91.00	€36.50	€12.12	20
May ’24	€39.14	€54.80 +40.0%	21.6%	€91.00	€33.07	€9.80	20
Apr ’24	€38.98	€54.83 +40.7%	21.5%	€91.00	€33.07	€11.41	20
Mar ’24	€39.00	€54.92 +40.8%	21.3%	€91.00	€33.07	€10.85	20
Feb ’24	€41.95	€55.29 +31.8%	21.1%	€91.00	€33.07	€12.24	20
Jan ’24	€36.42	€55.94 +53.6%	21.7%	€91.00	€33.07	€15.77	20
Dec ’23	€45.58	€56.57 +24.1%	21.6%	€91.00	€33.07	€15.67	19
Nov ’23	€43.78	€56.22 +28.4%	22.2%	€91.00	€33.07	€12.20	18

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

OIX

JP¥20.40

7D

1.0%

1Y

22.2%

Mutares SE KGaA

€484.6m

A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.

MUX

€22.40

7D

1.1%

1Y

-29.3%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$39.20

7D

5.9%

1Y

31.5%

Worldline Valuation